HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Geoffrey M Lynn Selected Research
Geoffrey M Lynn Research Topics
Disease
9
Neoplasms (Cancer)
05/2024 - 12/2017
2
Human Influenza (Influenza)
01/2023 - 10/2016
2
Malaria
01/2016 - 03/2015
1
Brain Neoplasms (Brain Tumor)
01/2019
1
Infections
01/2016
1
Parasitemia
01/2016
1
Tuberculosis (Tuberculoses)
03/2015
1
Bites and Stings (Sting)
03/2015
Drug/Important Bio-Agent (IBA)
7
Vaccines
IBA
05/2024 - 03/2015
5
Antigens
IBA
05/2024 - 03/2015
4
Peptides (Polypeptides)
IBA
05/2024 - 11/2022
4
Cancer Vaccines
IBA
11/2022 - 01/2020
2
Nanovaccines
IBA
05/2024 - 11/2022
2
Neoplasm Antigens (Tumor Antigens)
IBA
11/2022 - 01/2021
1
Toll-Like Receptor Agonists
IBA
05/2024
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
Interferon Type I
IBA
11/2022
1
Toll-Like Receptor 7
IBA
11/2022
1
Immune Checkpoint Inhibitors
IBA
10/2019
1
Immunologic Adjuvants (Immunologic Adjuvant)
IBA
10/2019
1
Micelles
IBA
10/2019
1
Polymers
IBA
10/2019
1
Albumins
IBA
12/2017
1
Subunit Vaccines
IBA
12/2017
1
Synthetic Vaccines (Recombinant Vaccines)
IBA
12/2017
1
Evans Blue (Blue, Evans)
FDA Link
12/2017
1
Albumin-Bound Paclitaxel
FDA Link
12/2017
1
Neutralizing Antibodies
IBA
10/2016
1
Epitopes
IBA
10/2016
1
1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)
IBA
01/2016
Therapy/Procedure
6
Immunotherapy
05/2024 - 12/2017
2
Therapeutics
01/2021 - 01/2019
1
Oncolytic Virotherapy
05/2024
1
Drug Therapy (Chemotherapy)
01/2021
1
Intravenous Administration
10/2019